SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001567619-20-021286
Filing Date
2020-12-17
Accepted
2020-12-17 17:38:38
Documents
1
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 3/A doc1.html 3/A  
1 FORM 3/A doc1.xml 3/A 6604
  Complete submission text file 0001567619-20-021286.txt   8109
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Issuer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PRECISION BIOSCIENCES, INC. 302 EAST PETTIGREW STREET, SUITE A-100 DURHAM NC 27701
Business Address
YAO TONY DUNG LING (Reporting) CIK: 0001771680 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39782 | Film No.: 201397231